Rheumatology International

, Volume 33, Issue 1, pp 239–240

Herpes zoster infection, vaccination and immunocompromised rheumatology patients

Short Communication

Abstract

Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.

Keywords

Herpes zoster infection Vaccination Immunocompromised Rheumatology patients 

References

  1. 1.
    Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT et al (2002) The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis 186(7):888–894PubMedCrossRefGoogle Scholar
  2. 2.
    Takahashi M, Okuno Y, Otsuka T, Osame J, Takamizawa A (1975) Development of a live attenuated varicella vaccine. Biken J 18(1):25–33PubMedGoogle Scholar
  3. 3.
    American Academy of Pediatrics Committee on Infectious Diseases (1995) Recommendations for the use of live attenuated varicella vaccine. Pediatrics 95(5):791–796Google Scholar
  4. 4.
    Thiry N, Beutels P, Van Damme P, Van Doorslaer E (2003) Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics 21(1):13–38PubMedCrossRefGoogle Scholar
  5. 5.
    Thomas SL, Wheeler JG, Hall AJ (2002) Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360(9334):678–682PubMedCrossRefGoogle Scholar
  6. 6.
    Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125(3):651–669PubMedCrossRefGoogle Scholar
  7. 7.
    Brisson M, Edmunds WJ, Gay NJ (2003) Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 70(Suppl 1):S31–S37PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Department of RheumatologySouth Infirmary Victoria University HospitalCorkIreland

Personalised recommendations